Technologies for the list were selected based on nominations. To be considered, the technologies had to meet four criteria — significant clinical impact and patient benefit over current technology, likelihood of commercial success, market availability starting 2015 and significant human interest in application/benefits. The list includes:
1. Mobile stroke units
2. Dengue fever vaccine
3. Quick, painless, low-cost blood testing
4. PCSK9 inhibitors for cholesterol reduction
5. Antibody-drug conjugates chemotherapy
6. Immune checkpoint inhibitors
7. Leadless cardiac pacemaker
8. New drugs for idiopathic pulmonary fibrosis
9. Single-dose intra-operative radiation therapy for breast cancer
10. New drug for heart failure Angiotensin-receptor neprilysin inhibitor
More articles on health IT:
12 recent vendor contracts, go-lives
Kaiser Permanete Hawaii patients can now send photos to physicians
Allscripts launches app for nurses
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.